Show simple item record

dc.contributor.authorSegarra, Nuriaen
dc.contributor.authorMetastasio, Antonioen
dc.contributor.authorZiauddeen, Hishamen
dc.contributor.authorSpencer, Jenniferen
dc.contributor.authorReinders, Niels Ren
dc.contributor.authorDudas, Roberten
dc.contributor.authorArrondo, Gonzaloen
dc.contributor.authorRobbins, Trevoren
dc.contributor.authorClark, Lukeen
dc.contributor.authorFletcher, Paulen
dc.contributor.authorMurray, Grahamen
dc.date.accessioned2015-12-08T16:17:26Z
dc.date.available2015-12-08T16:17:26Z
dc.date.issued2016-01-20en
dc.identifier.citationSegarra et al. Neuropsychopharmacology (2016). doi: 10.1038/npp.2015.370en
dc.identifier.issn0893-133X
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/252898
dc.description.sponsorshipSupported by a MRC Clinician Scientist award (G0701911), a Brain and Behaviour Research Foundation Young Investigator, and an Isaac Newton Trust award to Dr Murray; an award to Dr Segarra from the Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia and the European Union; by the University of Cambridge Behavioural and Clinical Neuroscience Institute, funded by a joint award from the Medical Research Council and Wellcome Trust (G1000183 and 093875/Z/10Z respectively); by awards from the Wellcome Trust (095692) and the Bernard Wolfe Health Neuroscience Fund to Professor Fletcher, and by awards from the Wellcome Trust Institutional Strategic Support Fund (097814/Z/11) and Cambridge NIHR Biomedical Research Centre. The authors are grateful for the help of clinical staff in CAMEO, in the Cambridge Rehabilitation and Recovery service and Pathways, and in the Cambridge IAPT service, for help with participant recruitment.
dc.languageEnglishen
dc.language.isoenen
dc.publisherNature Publishing Group
dc.rightsAttribution 2.0 UK: England & Wales
dc.rights.urihttp://creativecommons.org/licenses/by/2.0/uk/
dc.titleAbnormal frontostriatal activity during unexpected reward receipt in depression and schizophrenia: relationship to anhedoniaen
dc.typeArticle
dc.description.versionThis is the final version of the article. It first appeared from Nature Publishing Group via http://dx.doi.org/10.1038/npp.2015.370en
prism.publicationDate2016en
prism.publicationNameNeuropsychopharmacologyen
dcterms.dateAccepted2015-12-04en
rioxxterms.versionofrecord10.1038/npp.2015.370en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2016-01-20en
dc.contributor.orcidZiauddeen, Hisham [0000-0003-4044-1719]
dc.contributor.orcidDudas, Robert [0000-0001-6151-2630]
dc.contributor.orcidRobbins, Trevor [0000-0003-0642-5977]
dc.contributor.orcidFletcher, Paul [0000-0001-8257-1517]
dc.contributor.orcidMurray, Graham [0000-0001-8296-1742]
dc.identifier.eissn1740-634X
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idCambridgeshire and Peterborough NHS Foundation Trust (CPFT) (unknown)
pubs.funder-project-idMEDICAL RESEARCH COUNCIL (G0001354)
pubs.funder-project-idMRC (G0701911)
pubs.funder-project-idMRC (G1000183)
pubs.funder-project-idWellcome Trust (093875/Z/10/Z)
pubs.funder-project-idWellcome Trust (095692/Z/11/Z)
cam.orpheus.successThu Jan 30 12:55:30 GMT 2020 - The item has an open VoR version.*
rioxxterms.freetoread.startdate2300-01-01


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 2.0 UK: England & Wales
Except where otherwise noted, this item's licence is described as Attribution 2.0 UK: England & Wales